Intarcia Therapeutics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Intarcia Therapeutics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10283
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc, is a biopharmaceutical company that focuses on the development of therapies through its proprietary Medici Drug Delivery System, a subcutaneous delivery system to treat chronic conditions. The company’s product candidate includes ITCA 650, intended for the treatment of type II diabetes. It also carries out pipeline products in various therapeutic areas, including autoimmune diseases, obesity, HIV and other serious disorders. The company has manufacturing facility in Hayward, California; and research and development facility in Durham, North Carolina. Intarcia is headquartered in Boston, Massachusetts, the US.

Intarcia Therapeutics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Intarcia Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Intarcia Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Intarcia Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Intarcia Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Intarcia Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Intarcia Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Intarcia Therapeutics Raises US$200 Million In Venture Financing 10
Intarcia Therapeutics Raises US$210 Million In Venture Financing 12
Intarcia Therapeutics Raises USD0.7 Million in Venture Financing 14
Intarcia Therapeutics Raises Additional US$5.5 Million In Venture financing 15
Intarcia Therapeutics Plans To License Drug-Formulation Technology 16
Equity Offering 17
Intarcia Therapeutics Raises USD215 Million in First Tranche of Private Placement of Shares 17
Intarcia Therapeutics Inc – Key Competitors 18
Intarcia Therapeutics Inc – Key Employees 19
Intarcia Therapeutics Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Intarcia Therapeutics Inc, Medical Equipment, Key Facts 2
Intarcia Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Intarcia Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Intarcia Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Intarcia Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Intarcia Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Intarcia Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Intarcia Therapeutics Raises US$200 Million In Venture Financing 10
Intarcia Therapeutics Raises US$210 Million In Venture Financing 12
Intarcia Therapeutics Raises USD0.7 Million in Venture Financing 14
Intarcia Therapeutics Raises Additional US$5.5 Million In Venture financing 15
Intarcia Therapeutics Plans To License Drug-Formulation Technology 16
Intarcia Therapeutics Raises USD215 Million in First Tranche of Private Placement of Shares 17
Intarcia Therapeutics Inc, Key Competitors 18
Intarcia Therapeutics Inc, Key Employees 19
Intarcia Therapeutics Inc, Other Locations 20
Intarcia Therapeutics Inc, Subsidiaries 20

List of Figures
Intarcia Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Intarcia Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Intarcia Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Intarcia Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Intarcia Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Intarcia Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Intarcia Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Intarcia Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Intarcia Therapeutics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Teck Resources Ltd:戦略・SWOT・企業財務分析
    Teck Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Teck Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sempra Energy (SRE):電力:M&Aディール及び事業提携情報
    Summary Sempra Energy (Sempra) is an energy-services holding company. Through its subsidiaries, the company invests in, develops, and operates energy infrastructure. It carries out utility operations, development of energy infrastructure and related services in countries including the US, Mexico, Ar …
  • Blueberry Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a healthcare products provider that develops therapeutic products. The company develops novel therapies to treat onychomycosis. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea ped …
  • Western Area Power Administration:企業の戦略的SWOT分析
    Western Area Power Administration - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Shields Bag And Printing Company
    Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report Summary Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Pacific Textiles Holdings Ltd (1382):企業の財務・戦略的SWOT分析
    Pacific Textiles Holdings Ltd (1382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • OpGen Inc (OPGN):製品パイプライン分析
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • Tanami Gold NL:企業の戦略・SWOT・財務分析
    Tanami Gold NL - Strategy, SWOT and Corporate Finance Report Summary Tanami Gold NL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • China Investment Corp:企業のM&A・事業提携・投資動向
    China Investment Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Investment Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Macrogen Inc (038290):企業の財務・戦略的SWOT分析
    Macrogen Inc (038290) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • AusTex Oil Ltd:企業の戦略的SWOT分析
    AusTex Oil Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Agfa-Gevaert N.V.:戦略・SWOT・企業財務分析
    Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report Summary Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Z Energy Ltd:企業の戦略・SWOT・財務分析
    Z Energy Ltd - Strategy, SWOT and Corporate Finance Report Summary Z Energy Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • BWP Trust:企業の戦略・SWOT・財務情報
    BWP Trust - Strategy, SWOT and Corporate Finance Report Summary BWP Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Reinsurance Group of America, Incorporated:戦略・SWOT・企業財務分析
    Reinsurance Group of America, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Reinsurance Group of America, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Lysogene SAS (LYS):製薬・医療:M&Aディール及び事業提携情報
    Summary Lysogene SAS (Lysogene) is a clinical research center that offers basic research and clinical development programs. The center offers clinical development of gene therapy for neurodegenerative disorders such as Parkinson and Alzheimer diseases. It also develops models in gene therapy trials …
  • Murphy Oil Corporation (MUR):石油・ガス:M&Aディール及び事業提携情報
    Summary Murphy Oil Corp (Murphy) is an international independent oil and gas exploration and production company. It explores for and produces crude oil, natural gas, and natural gas liquids. The company operates oil and gas fields in the US, Canada, Malaysia, Australia, Brunei, Vietnam and Mexico. M …
  • US Foods, Inc.:企業の戦略・SWOT・財務分析
    US Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary US Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Arla Foods Ingredients Group P/S:企業の戦略・SWOT・財務情報
    Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report Summary Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Taisei Corporation:企業の戦略・SWOT・財務分析
    Taisei Corporation - Strategy, SWOT and Corporate Finance Report Summary Taisei Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆